TFPIC. difficileTcdB

Jianhua Luo1, Qi Yang1, Xiaofeng Zhang2

  • 1Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, Zhejiang 310024, China; Center for Infectious Disease Research, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang 310024, China; Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, Zhejiang 310024, China.

Cell
|March 18, 2022
PubMed
概括

高病毒性Clostridioides difficile菌株使用组织因子通路抑制剂 (TFPI) 作为受体. 这一发现显示TFPI是TcdB的结肠密码受体,为C. difficile感染的发病提供了新的见解.